MoonLake: Sonelokimab Phase 3 Week 40 Shows 62% Response MoonLake reports 62% Week 40 clinical response for sonelokimab in Phase 3 VELA trials (Mar 28, 2026); full safety and endpoint details pending.

MoonLake: Sonelokimab Phase 3 Week 40 Shows 62% Response: MoonLake reports 62% Week 40 clinical response for sonelokimab in Phase 3 VELA trials (Mar 28, 2026); full safety and endpoint details pending. 👈 Read full analysis #MoonLake #Sonelokimab #ClinicalTrials #Phase3 #AADMeeting

Join us at Moon Lake Library for a celebration honoring the strengths and resilience of women throughout history and present day.

📅 Date: March 29th📍 Location: Moon Lake Library
Invite your friends and family—everyone is welcome!
#WomensHistoryMonth #PWAC #MoonLake #CelebrateWomen

Investors Urged to Act as MoonLake Faces Lawsuit After Massive Stock Drop and Nanobody Controversy Investors of MoonLake Immunotherapeutics are reminded of the upcoming deadline for a securities class action lawsuit. Major claims surrounding its Nanobody technology face scrutiny after a staggering stock decline.

Investors Urged to Act as MoonLake Faces Lawsuit After Massive Stock Drop and Nanobody Controversy #United_States #San_Francisco #Hagens_Berman #MoonLake #Nanobody

Important Deadline Approaches for MoonLake Class Action Investors as Faruqi & Faruqi Warns of Legal Options Investors in MoonLake are reminded of a crucial lead plaintiff deadline for a class action lawsuit set for December 15, 2025. Legal insights are provided for affected shareholders.

Important Deadline Approaches for MoonLake Class Action Investors as Faruqi & Faruqi Warns of Legal Options #United_States #New_York #Class_Action #Faruqi #MoonLake

Berger Montague Files Class Action Against MoonLake Immunotherapeutics for Investor Representation Investors in MoonLake Immunotherapeutics (NASDAQ: MLTX) are urged to reach out to Berger Montague by December 15, 2025, regarding a class action lawsuit.

Berger Montague Files Class Action Against MoonLake Immunotherapeutics for Investor Representation #United_States #Class_Action #Philadelphia #Berger_Montague #MoonLake

MoonLake Immunotherapeutics Shareholders Alert: Important Class Action Announcement MoonLake Immunotherapeutics investors are urged to take action regarding a class action lawsuit with a lead plaintiff deadline approaching on December 15, 2025. Seek important details.

MoonLake Immunotherapeutics Shareholders Alert: Important Class Action Announcement #United_States #New_York #Gross_Law_Firm #MoonLake #MLTX

MLTX Investors Can Take Action Against MoonLake Immunotherapeutics in Fraud Case Investors in MoonLake Immunotherapeutics have a chance to join a class action lawsuit due to alleged securities fraud. The Schall Law Firm invites those affected to take part.

MLTX Investors Can Take Action Against MoonLake Immunotherapeutics in Fraud Case #USA #Los_Angeles #SecuritiesFraud #SchallLawFirm #MoonLake

MoonLake Immunotherapeutics Investors Have Chance to Join Securities Fraud Lawsuit Investors of MoonLake Immunotherapeutics (MLTX) who have incurred losses can now join a securities fraud class action lawsuit. Time is of the essence.

MoonLake Immunotherapeutics Investors Have Chance to Join Securities Fraud Lawsuit #USA #Class_Action #Los_Angeles #MoonLake #MLTX

Legal Action Alert: MoonLake Immunotherapeutics Faces Class Action Lawsuit for Securities Violations MoonLake Immunotherapeutics is facing a class action lawsuit for allegedly misrepresenting its drug's efficacy compared to competitors. Shareholders may be eligible for recovery.

Legal Action Alert: MoonLake Immunotherapeutics Faces Class Action Lawsuit for Securities Violations #United_States #DJS_Law_Group #Eastchester #MoonLake #MLTX

Investors with Over $100K Losses Can Join MoonLake Immunotherapeutics Class Action Investors who lost over $100K during the class period can lead a securities fraud lawsuit against MoonLake Immunotherapeutics. Act before December 15, 2025.

Investors with Over $100K Losses Can Join MoonLake Immunotherapeutics Class Action #Securities_Fraud #Rosen_Law_Firm #MoonLake

Investigating Legal Options: Faruqi & Faruqi's Action on MoonLake Investors' Claims Faruqi & Faruqi is investigating claims for investors of MoonLake Immunotherapeutics, guiding those affected by significant stock price drops.

Investigating Legal Options: Faruqi & Faruqi's Action on MoonLake Investors' Claims #USA #New_York #Securities_Law #Faruqi_&_Faruqi #MoonLake

MoonLake's Efficacy Claims Face Legal Challenges Amid 90% Stock Drop Recent claims from Hagens Berman reveal troubling gaps in MoonLake's SLK efficacy, plunging stock values, and potential legal actions for investors affected by these issues.

MoonLake's Efficacy Claims Face Legal Challenges Amid 90% Stock Drop #USA #San_Francisco #Hagens_Berman #MoonLake #MLTX

MoonLake Immunotherapeutics Investors Urged to Act by Deadline Amid Securities Fraud Lawsuit Investors in MoonLake Immunotherapeutics have a chance to join a class action lawsuit for alleged securities fraud. Deadline approaching.

MoonLake Immunotherapeutics Investors Urged to Act by Deadline Amid Securities Fraud Lawsuit #United_States #New_York #Securities_Fraud #Rosen_Law_Firm #MoonLake

MoonLake Immunotherapeutics Shareholders Have Chance to Lead Class Action Lawsuit for Securities Fraud MoonLake Immunotherapeutics investors who experienced significant losses can now take the opportunity to lead a class action lawsuit against the company for alleged securities fraud.

MoonLake Immunotherapeutics Shareholders Have Chance to Lead Class Action Lawsuit for Securities Fraud #None #Securities_Fraud #Bensalem #MoonLake #MLTX

MoonLake Immunotherapeutics Faces Class Action Lawsuit for Securities Violations MoonLake Immunotherapeutics is facing a class action lawsuit for alleged violations of securities laws. Affected investors can act before the deadline.

MoonLake Immunotherapeutics Faces Class Action Lawsuit for Securities Violations #United_States #New_York #Levi_Korsinsky #MoonLake #MLTX

Hagens Berman Investigates MoonLake's SLK Claims After Major Stock Drop Hagens Berman is diving into MoonLake Immunotherapeutics' claims regarding SLK's efficacy after a staggering 90% stock drop, focusing on undisclosed trial failures.

Hagens Berman Investigates MoonLake's SLK Claims After Major Stock Drop #USA #San_Francisco #Hagens_Berman #MoonLake #SLK

MoonLake Immunotherapeutics Shareholders Have Chance to Join Securities Class Action Suit Shareholders of MoonLake Immunotherapeutics who have incurred losses may now have the opportunity to lead a class action lawsuit related to securities fraud. Mark your calendars for the deadline.

MoonLake Immunotherapeutics Shareholders Have Chance to Join Securities Class Action Suit #USA #Los_Angeles #Securities_Fraud #MoonLake #MLTX

Investors Alert: Class Action Lawsuit Filed Against MoonLake Immunotherapeutics Amid Securities Fraud Allegations Investors in MoonLake Immunotherapeutics should be aware of a class action lawsuit with a deadline approaching. Learn how to protect your rights now.

Investors Alert: Class Action Lawsuit Filed Against MoonLake Immunotherapeutics Amid Securities Fraud Allegations #United_States #Philadelphia #Securities_Fraud #Berger_Montague #MoonLake

Faruqi & Faruqi Alerts MoonLake Investors About Class Action Deadline on December 15, 2025 Faruqi & Faruqi, LLP reminds investors in MoonLake of the upcoming deadline for lead plaintiff status in a securities class action lawsuit set for December 15, 2025.

Faruqi & Faruqi Alerts MoonLake Investors About Class Action Deadline on December 15, 2025 #USA #New_York #Faruqi_&_Faruqi #MoonLake #MLTX

Class Action Alert: MoonLake Immunotherapeutics Investors Can Participate in Securities Fraud Case MoonLake Immunotherapeutics investors are reminded of an upcoming deadline to lead a securities fraud lawsuit. Join now for potential compensation.

Class Action Alert: MoonLake Immunotherapeutics Investors Can Participate in Securities Fraud Case #USA #New_York #Securities_Fraud #Rosen_Law_Firm #MoonLake

Investors to Join MoonLake Immunotherapeutics Class Action for Alleged Securities Fraud by December 2025 A class action lawsuit has been initiated against MoonLake Immunotherapeutics over alleged securities fraud. Investors can join before December 2025.

Investors to Join MoonLake Immunotherapeutics Class Action for Alleged Securities Fraud by December 2025 #USA #New_York #Levi_&_Korsinsky #MoonLake #MLTX

MoonLake Immunotherapeutics Faces Lawsuit for Misleading Securities Practices Affecting Shareholders' Rights MoonLake Immunotherapeutics has come under fire with a lawsuit alleging securities law violations. Shareholders should act promptly to protect their rights.

MoonLake Immunotherapeutics Faces Lawsuit for Misleading Securities Practices Affecting Shareholders' Rights #USA #New_York #Securities_Law #MoonLake #MLTX

Faruqi & Faruqi, LLP Investigates MoonLake Immunotherapeutics Claims for Investors Faruqi & Faruqi, LLP is investigating potential claims against MoonLake Immunotherapeutics, urging affected investors to act before the deadline.

Faruqi & Faruqi, LLP Investigates MoonLake Immunotherapeutics Claims for Investors #United_States #New_York #Securities_Fraud #Faruqi_&_Faruqi #MoonLake

MoonLake Immunotherapeutics Faces Class Action Over Securities Violations: What Investors Need to Know Next Investors in MoonLake Immunotherapeutics are alerted to a class action lawsuit concerning securities fraud. Details and contact information provided.

MoonLake Immunotherapeutics Faces Class Action Over Securities Violations: What Investors Need to Know Next #USA #New_York #Levi_&_Korsinsky #MoonLake #MLTX

Class Action Lawsuit Filed Against MoonLake Immunotherapeutics for Securities Law Breaches Investors are urged to join a class action lawsuit against MoonLake Immunotherapeutics for alleged breaches of securities laws. Discover your rights and join the fight.

Class Action Lawsuit Filed Against MoonLake Immunotherapeutics for Securities Law Breaches #United_States #Los_Angeles #Lawsuit #MoonLake #MLTX

Investors of MoonLake Immunotherapeutics Encouraged to Join Class Action Lawsuit Investors who suffered losses from MoonLake Immunotherapeutics securities are urged to join a class action lawsuit led by Schall Law Firm before the December deadline.

Investors of MoonLake Immunotherapeutics Encouraged to Join Class Action Lawsuit #USA #Los_Angeles #Schall_Law_Firm #MoonLake #MLTX

MoonLake Immunotherapeutics Shareholders Face Class Action Fraud Opportunity Investors in MoonLake Immunotherapeutics who suffered losses can lead a class action lawsuit for alleged securities fraud. Key details inside.

MoonLake Immunotherapeutics Shareholders Face Class Action Fraud Opportunity #USA #Securities_Fraud #Bensalem #MoonLake #MLTX

Class Action Lawsuit Filed Against MoonLake Immunotherapeutics for Alleged Securities Fraud Investors in MoonLake Immunotherapeutics may be entitled to compensation due to a class action lawsuit alleging securities fraud. Act before the December deadline.

Class Action Lawsuit Filed Against MoonLake Immunotherapeutics for Alleged Securities Fraud #USA #New_York #Levi_&_Korsinsky #MoonLake #MLTX

Important Legal Notice for MoonLake Immunotherapeutics Investors: Berger Montague Class Action Lawsuit Update Investors of MoonLake Immunotherapeutics should be aware of an important class action lawsuit deadline. Ensure your rights are protected before it's too late.

Important Legal Notice for MoonLake Immunotherapeutics Investors: Berger Montague Class Action Lawsuit Update #United_States #Class_Action #Philadelphia #Berger_Montague #MoonLake

MoonLake Immunotherapeutics Faces Class-Action Lawsuit on Securities Violations MoonLake Immunotherapeutics is entangled in a securities law lawsuit, prompting shareholders to act before the December 15 deadline to protect their rights.

MoonLake Immunotherapeutics Faces Class-Action Lawsuit on Securities Violations #USA #New_York #Securities_Law #MoonLake #MLTX